50
Participants
Start Date
October 30, 2024
Primary Completion Date
October 30, 2025
Study Completion Date
January 31, 2026
Continues peripheral block
ropivacaine (Naropin) 0.2% according to a protocol 8-10 cc per hour up to 24 hours after surgery
Assaf-Harofeh Medical Center
OTHER_GOV